-
Real Time Chart
-
Stock Profile
-
Stock Fundamentals
Financials As Reported
- accession Number 0001437749-23-013767
- accounts Payable Current 6,968,000
- accounts Receivable Net Current 12,493,000
- accumulated Depreciation Depletion And Amortization Property Plant And Equipment 3,367,000
- accumulated Other Comprehensive Income Loss Net Of Tax --45,000
- allocated Share Based Compensation Expense 2,286,000
- amendment Flag false
- assets 112,954,000
- assets Current 95,973,000
- cash And Cash Equivalents At Carrying Value 36,540,000
- cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect --18,866,000
- cik 1,668,243
- city Area Code 646
- common Stock Par Or Stated Value Per Share 0.01
- common Stock Shares Authorized 100,000,000
- common Stock Shares Issued 23,440,521
- common Stock Shares Outstanding 23,400,000
- comprehensive Income Net Of Tax --30,151,000
- current Fiscal Year End Date --12-31
- date Filed 2023-05-11
- depreciation Depletion And Amortization 200,000
- document Fiscal Period Focus Q1
- document Fiscal Year Focus 2,023
- document Period End Date 2023-03-31
- document Transition Report false
- document Type 10-Q
- earnings Per Share Basic -1.3
- employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized 14
- employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition 1 P2Y1M6D
- entity Address Address Line 1 400 Alexander Park Drive
- entity Address City Or Town Princeton
- entity Address Postal Zip Code 8,540
- entity Address State Or Province NJ
- entity Central Index Key 1,668,243
- entity Current Reporting Status Yes
- entity Emerging Growth Company false
- entity File Number 001-38079
- entity Filer Category Non-accelerated Filer
- entity Incorporation State Country Code L3
- entity Interactive Data Current Yes
- entity Name UroGen Pharma Ltd.
- entity Registrant Name UroGen Pharma Ltd.
- entity Shell Company false
- entity Small Business true
- entity Tax Identification Number 98-1460746
- gross Profit 14,927,000
- income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest --30,192,000
- income Tax Expense Benefit 21,000
- increase Decrease In Accounts Receivable --211,000
- increase Decrease In Inventories 1,140,000
- inventory Net 5,466,000
- irs Number 0
- lessee Operating Lease Liability Payments Due 2,676,000
- lessee Operating Lease Liability Payments Due Next Twelve Months 930,000
- lessee Operating Lease Liability Payments Due Year Three 53,000
- lessee Operating Lease Liability Payments Due Year Two 816,000
- lessee Operating Lease Liability Undiscounted Excess Amount 305,000
- liabilities 229,508,000
- liabilities And Stockholders Equity 112,954,000
- liabilities Current 25,234,000
- local Phone Number 768-9780
- long Term Debt Noncurrent 97,941,000
- net Cash Provided By Used In Financing Activities 671,000
- net Cash Provided By Used In Investing Activities 6,270,000
- net Cash Provided By Used In Operating Activities --25,807,000
- net Income Loss --30,213,000
- nonoperating Income Expense --15,000
- operating Income Loss --22,045,000
- operating Lease Cost 228,000
- operating Lease Liability 2,371,000
- operating Lease Liability Noncurrent 1,403,000
- operating Lease Payments 294,000
- operating Lease Right Of Use Asset 2,329,000
- other Assets Noncurrent 3,160,000
- other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent 62,000
- other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 62,000
- other Liabilities Current 3,185,000
- payments To Acquire Property Plant And Equipment 23,000
- period End 1,680,220,800,000
- period Start 1,672,531,200,000
- proceeds From Issuance Of Long Term Debt 0
- proceeds From Maturities Prepayments And Calls Of Available For Sale Securities 30,469,000
- property Plant And Equipment Gross 4,470,000
- property Plant And Equipment Net 1,103,000
- report Link https://www.sec.gov/Archives/edgar/data/1668243/000143774923013767/urgn20230331_10q_htm.xml
- research And Development Expense 12,498,000
- retained Earnings Accumulated Deficit --607,300,000
- revenue From Contract With Customer Excluding Assessed Tax 17,192,000
- selling General And Administrative Expense 24,474,000
- share Based Compensation 2,286,000
- stockholders Equity --116,554,000
- trading Symbol URGN
- unrecognized Tax Benefits 3,000,000
- update 1970-01-01
- variable Lease Cost 19,000
- weighted Average Number Of Shares Outstanding Basic 23,279,951
- id REPORTED_FINANCIALS
- key URGN
- subkey 10-Q
- date 2023-05-11
- updated 2023-05-12
-
Symbol Info
-
Symbol Over View
-
Technical Analysis